Committees

Executive Committee

Members

Dr D. ALKER

David Alker Associates, Birchington, United Kingdom

Dr C. CONTINO-PEPIN

University of Avignon, Avignon, France

Dr P. GEORGE

SCT & Independent Scientific Expert & Adviser, Longvilliers, France

Prof. X. PANNECOUCKE

INSA Rouen, Saint Etienne du Rouvray, France

Prof. S. ROUTIER

Université d'Orléans, Orléans, France

Prof. J. SAPI

SCT & University of Reims-Champagne-Ardenne, Reims, France

Dr L. VAN HIJFTE

SCT & NovAliX, Nijmegen, The Netherlands

Prof. H. VAUDRY

University of Rouen, Mont-Saint-Aignan, France

Local Organising Committee

Members

Prof. T. BESSON

University of Rouen, COBRA-IRCOF, Rouen, France

Prof. J.-P. BOUILLON

University of Rouen, Mont Saint Aignan, France

Mrs N. DOUMENG

Technopole Chimie-Biologie-Santé, Val de Reuil, France

Prof. X. PANNECOUCKE

INSA Rouen, Saint Etienne du Rouvray, France

Dr D. VAUDRY

University of Rouen, Mont-Saint-Aignan, France

Prof. H. VAUDRY

University of Rouen, Mont-Saint-Aignan, France

Scientific Advisory Board

Members

Prof. F. ALBERICIO

Institute for Research in Biomedicine, Durban , South Africa

Prof. K.-H. ALTMANN

SCS DMCCB & Swiss Federal Institute of Technology, Zürich, Switzerland

Dr A. BARON

Edelris, Bristol, United Kingdom

Dr F. BEAULIEU

Omegachem, Québec, Canada

Dr A. BECK

Pierre Fabre, St Julien-en-Genevois, France

Dr C. BERTRAND

Ipsen, Les Ulis, France

Dr L. CASTRO

UCB, Slough, United Kingdom

Prof. A. CHARETTE

University of Montreal, Montreal, Canada

Prof. S. CHOI

Ewha Womans University, Seoul, Korea, South

Mr K. DACK

Leo Pharma, Ballerup, Denmark

Prof. P. DALLEMAGNE

University of Caen, Caen, France

Dr E. DEMONT

GSK, Stevenage, United Kingdom

Prof. G. ECKER

University of Vienna, Vienna, Austria

Dr R. GOSMINI

NovAliX, llkirch-Graffenstaden, France

Dr A. HALL

Eisai, Hertfordshire, United Kingdom

Dr H. HASHIMOTO

Japan Tobacco, Takatsuki, Japan

Dr C. HEDGECOCK

Uppsala University, Consultant DiversiQuem, Uppsala, Sweden

Prof. A. P. IJZERMAN

Leiden University, Leiden, The Netherlands

Dr K. KATAOKA

Teijin Pharma Limited, Tokyo, Japan

Dr F. LEEMHUIS

Mercachem-Syncom, Nijmegen, The Netherlands

Dr I. LEWIS

Novartis, Basel, Switzerland

Prof. J. MARTINEZ

University of Montpellier, Montpellier, France

Dr V. MIKOL

Sanofi, Vitry-sur-Seine, France

Prof. P. MONSAN

INSA, Toulouse, France

Dr H. PRIEPKE

Boehringer-Ingelheim, Ingelheim, Germany

Prof. J. REICHERT

Tufts University, Boston, United States

Dr H. SCHIROK

Bayer, Wuppertal, Germany

Dr P. SENECI

University of Milan, Milan, Italy

Prof. W. SIPPL

Martin-Luther-Universität Halle-Wittenberg, Halle, Germany

Dr J.-P. SURIVET

Actelion, Allschwil, Switzerland

Dr M. TANAKA

Daiichi Sankyo RD Novare, Tokyo, Japan

Dr G. TANG

Roche, Shanghai, China

Dr A. TORRENS

Esteve Pharmaceuticals, Barcelona, Spain

Dr K. VAN EMELEN

Janssen, Beerse, Belgium

Dr K. ZHANG

RIKEN, Yokohama, Japan